Procter & Gamble stock stays anchored by fiscal 2025 growth

Procter & Gamble stock reflects the consumer staples group’s fiscal 2025 scale, with net sales of $84.0 billion, diluted EPS of $6.51, and operating cash flow of $18.8 billion in the year ended 30 June 2025.

Fiscal 2025 sets the base

The company said fiscal 2025 net sales were $84.0 billion, while organic sales grew 2% and core earnings per share rose 4% to $6.83, according to its latest investor materials. Operating cash flow reached $18.8 billion in fiscal 2025, and free cash flow productivity was 87%, showing how cash generation continues to underpin the dividend profile.

Margin and cash remain key

Gross margin was 51.4% in fiscal 2025, and adjusted free cash flow productivity improved versus prior years as the company kept returning cash to shareholders. Net earnings attributable to Procter & Gamble were $15.7 billion, up from $14.7 billion in fiscal 2024, which gives the current valuation backdrop a larger earnings base.

For investors, the comparison that matters is simple: fiscal 2025 sales rose to $84.0 billion from $84.0 billion a year earlier in reported terms, while core EPS moved to $6.83 from $6.57, according to the company. That leaves margin execution and volume discipline more important than headline growth alone.

Brands drive the mix

Beauty, grooming, health care, fabric and home care, and baby, feminine and family care remain the core operating segments, and the company continues to lean on household brands such as Tide, Pampers, Gillette, and Oral-B. Those brands are the commercial engine behind the 2% organic sales growth in fiscal 2025 and the 4% rise in core EPS.

Stock view stays tied to scale

With no current price data in this article, the market reference point is the company’s fiscal 2025 scale and earnings mix rather than a live quote. Procter & Gamble remains a large-cap consumer staples name with $84.0 billion in fiscal 2025 sales, $6.83 in core EPS, and $18.8 billion in operating cash flow.